Interaction of benztropine and haloperidol actions on rat substantia nigra dopamine cell electrophysiological activity in vivo

Brain Research Bulletin

Volumn 48, Issue 2, 1999, Pages 219-222

  Todd, Christopher L ^a   Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Acute dystonia; Antipsychotic drugs; Dopamine; Dopamine transporter; Extrapyramidal side effects; Muscarinic; Single unit recording

Indexed keywords

BENZATROPINE; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; MALE; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; BENZTROPINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; HALOPERIDOL; MALE; MUSCARINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0033555645     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(98)00166-X     Document Type: Article

References (28)

1. Ayd, F. J. A survey of drug-induced extrapyramidal reactions. JAMA 175:1054-1060; 1961.
2. Batsche, K.; Granhoff, M. I.; Wang, R. Y. 5-HT3 receptor antagonists fail to block the suppressant effect of cocaine on the firing rate of A10 dopamine neurons in the rat. Brain Res. 592:273-277; 1992.
3. Brodie, M. S.; Dunwiddie, T. V. Cocaine effects in the ventral tegmental area: Evidence for an indirect dopaminergic mechanism of action. Naunyn-Schmiedebergs Arch. Pharmacol. 342:660-665; 1990.
4. Bunney, B. S.; Grace, A. A. Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sci. 23:1715-1728; 1978.
5. Bunney, B. S.; Walters, J. R.; Roth, R. H.; Aghajanian, G. K. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185:560-571; 1973.
6. Casey, D. E.; Gerlach, J.; Christensson, E. Dopamine, acetylcholine, and GABA effects in acute dystonia in primates. Psychopharmacol. 70:83-87; 1980.
7. Chiodo, L. A.; Bunney, B. S. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J. Neurosci. 5:2539-2544; 1985.
8. Church, W. H.; Justice, J. B.; Byrd, L. D. Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine, and benztropine. Eur. J. Pharmacol. 139:345-348; 1987.
9. Cortes, R.; Palacios, J. M. Muscarinic cholinergic receptor subtypes in rat brain, I: Quantitative autoradiographic studies. Brain Res. 362:227-238; 1986.
10. Darlington, R. B. Regression and linear models. New York: McGraw-Hill; 1990.
11. Dersch, C. M.; Akunne, H. C.; Partilla, J. S.; Char, G. U.; de Costa, B. R.; Rice, K. C.; Carrol, F. I.; Rothman, R. B. Studies of the biogenic amine transporters, 1: Dopamine reuptake blockers inhibit 3[H]Mazindol binding to the dopamine transporter by a competitive mechanism: Preliminary evidence for different binding domains. Neurochem. Res. 19:201-208; 1994.
12. Einhorn, L. C.; Johansen, P. A.; White, F. J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Studies in the ventral tegmental area. J. Neurosci. 8:100-112; 1988.
13. Engberg, G.; Elverfors, A.; Jonason, J.; Nissbrandt, H. Inhibition of dopamine reuptake: Significance for nigral dopamine neuron activity. Synapse 25:215-226; 1997.
14. Grace, A. A.; Bunney, B. S. The control of firing pattern in nigral dopamine neurons: Burst firing. J. Neurosci. 4:2877-2890; 1984.
15. Itoh, K.; Ikarashi, Y.; Way, E. L.; Maruyama, Y. Intrastriatal dialysis evidence for a direct inhibitory effect of benztropine on dopamine re-uptake. Neurosci. Lett. 125:22-24; 1991.
16. Izenwasser, S.; Terry, P.; Heller, B.; Witkin, J. M.; Katz, J. L. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors. Eur. J. Pharmacol. 263: 277-283; 1994.
17. Kadishevitz, L.; Brudzynski, S. M. Functional pattern of cholinergic input to the ventral tegmental area in the rat. Soc. Neurosci. Abstr. 23:1493; 1997.
18. Lacey, M. G.; Calabresi, P.; North, R. A. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J. Pharmacol. Exp. Ther. 253:395-400; 1990.
19. Nastuk, M. A.; Graybiel, A. M. Pharmacologically defined M1 and M2 muscarinic cholinergic binding sites in the cat's substantia nigra: Development and maturity. Devel. Brain Res. 61:1-10; 1991.
20. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates, compact 3rd ed., CD-ROM. San Diego: Academic Press; 1996.
21. Pucak, M. L.; Grace, A. A. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J. Pharmacol. Exp. Ther. 271:1181-1192; 1994.
22. Sramek, J. J.; Simpson, G. M.; Morrison, R. L.; Heiser, J. F. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: A prospective study. J. Clin. Psychiatry 47:305-309; 1986.
23. Stanilla, J. K.; Simpson, G. M. Drugs to treat extrapyramidal side effects. In: Schatzberg, A. F.; Nemeroff, C. B., eds. The American Psychiatric Press textbook of psychopharmacology. Washington, DC: American Psychiatric Press; 1995:281-299.
24. Studer, A.; Schultz, W. The catecholamine uptake inhibitor nomifensine depresses impulse activity of dopamine neurons in mouse substantia nigra. Neurosci. Lett. 80:207-212; 1987.
25. Todd, C. L.; Cameron, W.; Grace, A. A. Modulation of substantia nigra dopamine neuron activity by muscarinic antagonist administration. Soc. Neurosci. Abstr. 21:1660; 1995.
26. Weiner, D. M.; Levey, A. I.; Brann, M. R. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat substantia nigra. Proc. Natl. Acad. Sci. 87:7050-7054; 1990.
27. Winslow, R. S.; Stillner, V.; Coons, D. J.; Robinson, M. W. Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics. Am. J. Psychiatry 143:706-710; 1986.
28. Zubieta, J. K.; Frey, K. A. Autoradiographic mapping of M3 muscarinic receptors in the rat brain. J. Pharmacol. Exp. Ther. 264:415-422; 1993.